| Names | |
|---|---|
| IUPAC name 17-Methyl-7,8-didehydro-4,5α-epoxymorphinan-3,6α,14-triol | |
| Systematic IUPAC name (4R,4aS,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-4a,7,9-triol | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C17H19NO3 | |
| Molar mass | 301.34 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
14-Hydroxymorphine is a semi-synthetic opioid, chemical compound closely related to alkaloid morphine, characterized by an additional hydroxyl group at the 14th position.
It is a potential precursor or metabolite of other potent opioids [1] , such as oxymorphone (which is 14-hydroxydihydromorphinone). Its chemical structure includes the basic morphine skeleton with additional complexity at the 14th carbon atom, It is primarily of interest in chemical and pharmacological research as an intermediate in the synthesis of more potent semi-synthetic opioids. [2] [3] [4]
14-hydroxymorphine acts primarily as a μ-opioid receptor (MOR) agonist. It also exhibits some activity at other opioid receptors, but its primary action is at the MOR. [4]